Cellectis SA (CLLS)
1.43
+0.03
(+2.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.41
-0.02
(-1.40%)
After-Hours: 20:00
Cellectis Profit Margin (Quarterly) : -417.3% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -417.3% |
| March 31, 2026 | -307.5% |
| December 31, 2025 | -253.1% |
| September 30, 2025 | 1.67% |
| June 30, 2025 | -141.9% |
| March 31, 2025 | -170.1% |
| December 31, 2024 | 46.57% |
| September 30, 2024 | -142.3% |
| June 30, 2024 | -313.5% |
| March 31, 2024 | |
| December 31, 2023 | -22.48K% |
| September 30, 2023 | -11.28K% |
| June 30, 2023 | -16.70K% |
| March 31, 2023 | -20.02K% |
| December 31, 2022 | -160.4% |
| September 30, 2022 | -14.60K% |
| June 30, 2022 | -1.45K% |
| March 31, 2022 | -1.70K% |
| December 31, 2021 | -230.1% |
| September 30, 2021 | -482.1% |
| June 30, 2021 | -372.3% |
| March 31, 2021 | -59.94% |
| December 31, 2020 | -327.0% |
| Date | Value |
|---|---|
| September 30, 2020 | -543.8% |
| June 30, 2020 | -1.24K% |
| March 31, 2020 | 33.12% |
| December 31, 2019 | -930.5% |
| September 30, 2019 | -229.6% |
| June 30, 2019 | -3.18K% |
| March 31, 2019 | -1.71K% |
| December 31, 2018 | -2.69K% |
| September 30, 2018 | -2.79K% |
| June 30, 2018 | -192.9% |
| March 31, 2018 | -447.6% |
| December 31, 2017 | -501.7% |
| September 30, 2017 | -475.3% |
| June 30, 2017 | -408.1% |
| March 31, 2017 | -293.4% |
| December 31, 2016 | -164.1% |
| September 30, 2016 | -124.8% |
| June 30, 2016 | -39.53% |
| March 31, 2016 | -422.2% |
| December 31, 2015 | 30.54% |
| September 30, 2015 | -168.0% |
| June 30, 2015 | -302.5% |
| March 31, 2015 | 74.94% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Akari Therapeutics Plc | -- |
| Autolus Therapeutics Plc | -85.60% |
| Evaxion AS | -- |
| Bicycle Therapeutics Plc | -8.00K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -87.23% |
| Return on Assets | -20.61% |
| Return on Invested Capital | -34.74% |
| Gross Profit Margin (Quarterly) | 15.62% |
| Operating Margin (Quarterly) | -487.4% |
| Return on Net Operating Assets | -88.13% |